Intravenous iron for critically ill children. Comparison of three dose regimens.
intravenous iron
iron sucrose
iron-deficiency anemia
pediatric critical care
pediatrics
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
revised:
01
10
2023
received:
30
04
2023
accepted:
09
10
2023
medline:
24
11
2023
pubmed:
26
10
2023
entrez:
26
10
2023
Statut:
ppublish
Résumé
Anemia is extremely common among patients admitted to pediatric intensive care. Alternative treatments to transfusions such as intravenous iron must be considered. There are no published data for a prospective intravenous (IV) iron study focused in the critically ill children. The objective is to examine the safety and efficacy of intravenous iron sucrose infusion to manage anemia in pediatric critical care. A secondary objective is to examine the effect of different dose regimens of iron sucrose (3, 5, and 7 mg/kg dose). Prospective investigation of intravenous iron sucrose utilization at a tertiary pediatric intensive care unit between October 2017 and November 2022. In all 115 patients received a total of 616 infusions of IV iron. Transferrin saturation index (TSI) was the most common altered iron deficiency biomarker (91.8%). After IV iron treatment, hemoglobin showed a significant increase within a 30-day follow-up (9.2 vs. 11.6 g/dL, p < .001). There was also a significant improvement in TSI and serum iron (p < .001). Iron deficit replacement was higher in the 7 mg/kg dose group (94%) compared to 85.9% in the 5 mg/kg regimen and 77.5% in the lower dose group (p = .008), requiring less doses and a shorter time. Very few mild adverse reactions were reported (1.3% of infusions), with no differences between groups. The most frequent adverse effect was gastrointestinal in three cases. There were no anaphylaxis-like or other serious/life-threatening adverse effects. This is the first study to evaluate intravenous iron therapy in pediatric critical care, providing preliminary evidence of safety and efficacy of IV iron sucrose. The 7 mg/kg dose regimen showed higher iron deficit replacement in a shorter time, which could be beneficial in critically ill children.
Sections du résumé
BACKGROUND
BACKGROUND
Anemia is extremely common among patients admitted to pediatric intensive care. Alternative treatments to transfusions such as intravenous iron must be considered. There are no published data for a prospective intravenous (IV) iron study focused in the critically ill children. The objective is to examine the safety and efficacy of intravenous iron sucrose infusion to manage anemia in pediatric critical care. A secondary objective is to examine the effect of different dose regimens of iron sucrose (3, 5, and 7 mg/kg dose).
PROCEDURE
METHODS
Prospective investigation of intravenous iron sucrose utilization at a tertiary pediatric intensive care unit between October 2017 and November 2022.
RESULTS
RESULTS
In all 115 patients received a total of 616 infusions of IV iron. Transferrin saturation index (TSI) was the most common altered iron deficiency biomarker (91.8%). After IV iron treatment, hemoglobin showed a significant increase within a 30-day follow-up (9.2 vs. 11.6 g/dL, p < .001). There was also a significant improvement in TSI and serum iron (p < .001). Iron deficit replacement was higher in the 7 mg/kg dose group (94%) compared to 85.9% in the 5 mg/kg regimen and 77.5% in the lower dose group (p = .008), requiring less doses and a shorter time. Very few mild adverse reactions were reported (1.3% of infusions), with no differences between groups. The most frequent adverse effect was gastrointestinal in three cases. There were no anaphylaxis-like or other serious/life-threatening adverse effects.
CONCLUSIONS
CONCLUSIONS
This is the first study to evaluate intravenous iron therapy in pediatric critical care, providing preliminary evidence of safety and efficacy of IV iron sucrose. The 7 mg/kg dose regimen showed higher iron deficit replacement in a shorter time, which could be beneficial in critically ill children.
Substances chimiques
Ferric Oxide, Saccharated
FZ7NYF5N8L
Iron
E1UOL152H7
Glucaric Acid
QLZ991V4A2
Hemoglobins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e30734Informations de copyright
© 2023 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.
Références
Bateman ST, Lacroix J, Boven K, et al. Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. Am J Respir Crit Care Med. 2008;178(1):26-33.
Demaret P, Valla FV, Behal H, et al. Anemia at discharge from the PICU: a bicenter descriptive study. Pediatr Crit Care Med. 2019;20(9):e400-e409.
Demaret P, Karam O, Tucci M, et al. Anemia at pediatric intensive care unit discharge: prevalence and risk markers. Ann Intensive Care. 2017;7:107.
Allnutt B, Stanworth S, Ray S. Prevalence of anaemia in patients discharged from the paediatric intensive care unit. Transfus Med. 2020;30(6):513-514.
Lasocki S, Asfar P, Jaber S, et al. Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial. Crit Care. 2021;25:62.
Lasocki S, Chudeau N, Papet T, et al. Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study. Crit Care. 2014;18(5):542.
Asare K. Anemia of critical illness. Pharmacotherapy. 2008;28:1267-1282.
Horwitz SMC, Kelleher K, Thomas Boyce PMT, et al. Anemia and blood transfusion in critically ill patients. J Am Med Assoc. 2002;288(12):1499-1507.
Valentine SL, Bembea MM, Muszynski JA, et al. Consensus recommendations for RBC transfusion practice in critically ill children from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med. 2018;19:884-898.
Mattiello V, Schmugge M, Hengartner H, von der Weid N, Renella R. Diagnosis and management of iron deficiency in children with or without anemia: consensus recommendations of the SPOG Pediatric Hematology Working Group. Eur J Pediatr. 2020;179(4):527-545.
Goyal A, Zheng Y, Albenberg LG, et al. Anemia in children with inflammatory bowel disease: a position paper by the IBD Committee of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2020;71:563-582.
Geneen LJ, Kimber C, Doree C, Stanworth S, Shah A. Efficacy and safety of intravenous iron therapy for treating anaemia in critically ill adults: a rapid systematic review with meta-analysis. Transfus Med Rev. 2022;36:97-106.
The IRONMAN Investigators, Litton E, Baker S, et al. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: a randomized trial of IV iron in critical illness. Intensive Care Med. 2016;42:1715-1722.
Shah A, Chester-Jones M, Dutton SJ, et al. Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial. Br J Anaesth. 2022;128(2):272-282.
Shah A, Fisher SA, Wong H, et al. Safety and efficacy of iron therapy on reducing red blood cell transfusion requirements and treating anaemia in critically ill adults: a systematic review with meta-analysis and trial sequential analysis. J Crit Care. 2019;49:162-171.
Arastu AH, Elstrott BK, Martens KL, et al. Analysis of adverse events and intravenous iron infusion formulations in adults with and without prior infusion reactions. JAMA Netw Open. 2022;5(3):e224488.
Kliegman R, Stanton BF, St-Geme III JW, et al. Nelson's Textbook of Pediatrics. Elsevier; 2020:2505-2509.
Tahmasebi H, Higgins V, Kathryn Bohn M, Hall A, Adeli K. Improving laboratory test interpretation in children (Beckman Coulter DxH 900-Core Laboratory Hematology System). Am J Clin Pathol. 2020;154(3):330-341.
Dignass A, Farrag K, Stein J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chronic Dis. 2018;2018:9394060.
Cappellini MD, Musallam KM, Taher AT. Iron deficiency anaemia revisited. J Intern Med. 2020;287(2):153-170.
Muñoz M, Romero A, Morales M, Campos A, García-Erce JA, Ramírez G. Iron metabolism, inflammation and anemia in critically ill patients. A cross-sectional study. Nutr Hosp. 2005;20(2):115-120.
Mantadakis E. Advances in pediatric intravenous iron therapy. Pediatr Blood Cancer. 2016;63:11-16.
Kaneva K, Chow E, Rosenfield CG, Kelly MJ. Intravenous iron sucrose for children with iron deficiency anemia. J Pediatr Hematol Oncol. 2017;39(5):e259-e262.
Gómez-Ramírez S, Bisbe E, Shander A, Spahn DR, Muñoz M. Management of perioperative iron deficiency anemia. Acta Haematol. 2019;142(1):21-29.
Miles LF, Richards T. Hematinic and iron optimization in peri-operative anemia and iron deficiency. Curr Anesthesiol Rep. 2022;12(1):65-77.
Wang CY, Babitt JL. Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 2016;23(3):189-197.
Litton E, Baker S, Erber W, et al. Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study. J Intensive Care. 2018;6:60.
Assouline B, Benoliel A, Zamberg I, et al. Intravenous iron supplementation after liver surgery: impact on anemia, iron, and hepcidin levels-a randomized controlled trial. Surgery. 2021;170(3):813-821.
Shah A, Roy NB, McKechnie S, Doree C, Fisher SA, Stanworth SJ. Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis. Crit Care. 2016;20(1):306.
Lasocki S, Pène F, Ait-Oufella H, et al. Management and prevention of anemia (acute bleeding excluded) in adult critical care patients. Ann Intensive Care. 2020;10(1).
Muñoz M, Gómez-Ramírez S. Is there a role for iron supplementation in critically ill patients? Med Intensiva. 2019;43:103-107.
Warner MA, Shore-Lesserson L, Shander A, Patel SY, Perelman SI, Guinn NR. Perioperative anemia: prevention, diagnosis, and management throughout the spectrum of perioperative care. Anesth Analg. 2020;130(5):1364-1380.
Ozsahin H, Schaeppi M, Bernimoulin M, Allard M, Guidard C, van den Ouweland F. Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: benefits and risks in a cohort of 144 children and adolescents. Pediatr Blood Cancer. 2020;67:e28614.
Boucher AA, Pfeiffer A, Bedel A, Young J, McGann PT. Utilization trends and safety of intravenous iron replacement in pediatric specialty care: a large retrospective cohort study. Pediatr Blood Cancer. 2018;65(6):2-7.
Sabe R, Vatsayan A, Mahran A, Khalili AS, Ahuja S, Sferra TJ. Safety and efficacy of intravenous iron sucrose for iron-deficiency anemia in children and adolescents with inflammatory bowel disease. Glob Pediatr Heal. 2019;6:2333794X19870981.
Kaneva K, Chow E, Rosenfield CG, Kelly MJ. Intravenous iron sucrose for children with iron deficiency anemia. J Pediatr Hematol Oncol. 2017;39:e259-e262.
Perelman I, Winter R, Sikora L, Martel G, Saidenberg E, Fergusson D. The efficacy of postoperative iron therapy in improving clinical and patient-centered outcomes following surgery: a systematic review and meta-analysis. Transfus Med Rev. 2018;32:89-101.
Betar N, Warren J, Adams J, Herbert D, Vujcich E, Maitz PBJ. Intravenous iron therapy to treat burn anaemia: a retrospective cohort study. Burns. 2023;49(4):813-819.
Shokri H, Ali I. Intravenous iron supplementation treats anemia and reduces blood transfusion requirements in patients undergoing coronary artery bypass grafting-a prospective randomized trial. Ann Card Anaesth. 2022;25(2):141-147.
Schack A, Berkfors AA, Ekeloef S, Gögenur I, Burcharth J. The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World J Surg. 2019;43(7):1677-1691.
Mantadakis E. Intravenous iron: safe and underutilized in children. Pediatr Blood Cancer. 2018;65(6):e27016.
Boucher AA, Bedel A, Jones S, Lenahan SF, Geer R, McGann PT. A retrospective study of the safety and efficacy of low molecular weight iron dextran for children with iron deficiency anemia. Pediatr Blood Cancer. 2021;68(7):e29024.
Heming N, Lettéron P, Driss F, et al. Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia. Crit Care Med. 2012;40(7):2141-2148.
Lasocki S, Piednoir P, Couffignal C, et al. Does IV iron induce plasma oxidative stress in critically ill patients? A comparison with healthy volunteers. Crit Care Med. 2016;44(3):521-530.
Golonka R, Yeoh BS, Vijay-Kumar M. The iron tug-of-war between bacterial siderophores and innate immunity. J Innate Immun. 2019;11(3):249-262.